Man Group’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.35M | Buy |
430,904
+135,162
| +46% | +$2.93M | 0.02% | 687 |
|
|
2025
Q1 | $7.17M | Sell |
295,742
-20,075
| -6% | -$487K | 0.02% | 733 |
|
|
2024
Q4 | $6.59M | Buy |
315,817
+61,123
| +24% | +$1.28M | 0.02% | 791 |
|
|
2024
Q3 | $5.06M | Sell |
254,694
-215,150
| -46% | -$4.28M | 0.01% | 911 |
|
|
2024
Q2 | $7.28M | Sell |
469,844
-149,567
| -24% | -$2.32M | 0.02% | 784 |
|
|
2024
Q1 | $9.87M | Sell |
619,411
-24,805
| -4% | -$395K | 0.02% | 678 |
|
|
2023
Q4 | $10.8M | Buy |
+644,216
| New | +$10.8M | 0.03% | 582 |
|
|
2023
Q3 | – | Sell |
-835,008
| Closed | -$11.2M | – | 707 |
|
|
2023
Q2 | $11.2M | Buy |
+835,008
| New | +$11.2M | 0.03% | 583 |
|
|
2023
Q1 | – | Sell |
-889,532
| Closed | -$16.5M | – | 427 |
|
|
2022
Q4 | $16.5M | Buy |
889,532
+102,432
| +13% | +$1.91M | 0.06% | 397 |
|
|
2022
Q3 | $10.1M | Buy |
+787,100
| New | +$10.1M | 0.05% | 468 |
|
|
2022
Q2 | – | Sell |
-256,100
| Closed | -$2.12M | – | 1099 |
|
|
2022
Q1 | $2.12M | Sell |
256,100
-136,800
| -35% | -$1.13M | 0.01% | 1195 |
|
|
2021
Q4 | $2.66M | Buy |
392,900
+87,000
| +28% | +$589K | 0.01% | 1092 |
|
|
2021
Q3 | $1.62M | Hold |
305,900
| – | – | 0.01% | 1218 |
|
|
2021
Q2 | $1.76M | Sell |
305,900
-58,327
| -16% | -$335K | 0.01% | 1253 |
|
|
2021
Q1 | $1.68M | Sell |
364,227
-629,335
| -63% | -$2.9M | 0.01% | 1161 |
|
|
2020
Q4 | $3.32M | Sell |
993,562
-141,500
| -12% | -$473K | 0.01% | 993 |
|
|
2020
Q3 | $3.37M | Buy |
1,135,062
+85,327
| +8% | +$253K | 0.01% | 1001 |
|
|
2020
Q2 | $4.85M | Buy |
1,049,735
+941,435
| +869% | +$4.35M | 0.02% | 676 |
|
|
2020
Q1 | $417K | Buy |
108,300
+34,500
| +47% | +$133K | ﹤0.01% | 1314 |
|
|
2019
Q4 | $277K | Buy |
+73,800
| New | +$277K | ﹤0.01% | 1685 |
|